Pages that link to "Q34688788"

The following pages link to Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). (Q34688788):

Displaying 38 items.

• Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse (Q26746336) (← links)
• Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections (Q28088477) (← links)
• Effect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individuals (Q28260551) (← links)
• Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder (Q33694166) (← links)
• Host genetic factors predisposing to HIV-associated neurocognitive disorder (Q34001122) (← links)
• Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin. (Q34281340) (← links)
• Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). (Q35023273) (← links)
• Sustained-release nanoART formulation for the treatment of neuroAIDS (Q35082009) (← links)
• Drugs of Abuse in HIV infection and neurotoxicity (Q35212027) (← links)
• Evolutionary distance of amino acid sequence orthologs across macaque subspecies: identifying candidate genes for SIV resistance in Chinese rhesus macaques (Q35462419) (← links)
• HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity (Q35702075) (← links)
• Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. (Q35708840) (← links)
• DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine (Q35895155) (← links)
• Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits (Q35953242) (← links)
• HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders (Q36010129) (← links)
• Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue. (Q36093283) (← links)
• Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS. (Q36218958) (← links)
• Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages (Q37019304) (← links)
• Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection (Q37234713) (← links)
• Electrochemical monitoring-on-chip (E-MoC) of HIV-infection in presence of cocaine and therapeutics (Q37266049) (← links)
• Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment (Q37714669) (← links)
• Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS. (Q38761022) (← links)
• Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms (Q38830540) (← links)
• Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation. (Q39276123) (← links)
• Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS. (Q40089319) (← links)
• Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS. (Q40111779) (← links)
• HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution (Q40806200) (← links)
• HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum. (Q47105825) (← links)
• Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain. (Q47548818) (← links)
• Migrainomics - identifying brain and genetic markers of migraine (Q47965672) (← links)
• Potentiation of Surface Stability of AMPA Receptors by Sulfhydryl Compounds: A Redox-Independent Effect by Disrupting Palmitoylation (Q48444921) (← links)
• Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors. (Q54979705) (← links)
• Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers (Q56777442) (← links)
• L-Lactate Regulates the Expression of Synaptic Plasticity and Neuroprotection Genes in Cortical Neurons: A Transcriptome Analysis (Q58575964) (← links)
• HIV influences microtubule associated protein-2: Potential marker of HIV-associated neurocognitive disorders (Q89775600) (← links)
• Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder (Q91636842) (← links)
• Development of Multifunctional Biopolymeric Auto-Fluorescent Micro- and Nanogels as a Platform for Biomedical Applications (Q95277161) (← links)
• HIV-Tat and Cocaine Impact Brain Energy Metabolism: Redox Modification and Mitochondrial Biogenesis Influence NRF Transcription-Mediated Neurodegeneration (Q99728806) (← links)